Sat.Dec 16, 2023 - Fri.Dec 22, 2023

article thumbnail

The Advantages of Decentralized Clinical Trials in Diabetes Research

Crucial Data Soutions

The growth of decentralized clinical trial (DCT) strategies may be happening slower than many expected, but it is definitely happening. The post The Advantages of Decentralized Clinical Trials in Diabetes Research appeared first on Crucial Data Solutions.

article thumbnail

AI-driven text analytics improve clinical trial processes

pharmaphorum

AI-driven text analytics can revolutionise the clinical trial process by improving data collection and analysis in the biopharma industry. Learn how this technology can enhance efficiency and patient outcomes.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Removing Language as a Barrier for Clinical Trial Participants

Velocity Clinical Research

Velocity Clinical Research is committed to inclusivity and ensuring that everyone, regardless of their nationality or spoken language, can participate in groundbreaking clinical research studies. Language should never be a barrier to advancing medicine, and so, in collaboration with Boostlingo, we offer live phone and video interpretation services in over 300 languages.

article thumbnail

Grand Rounds December 15, 2023: Diversifying Clinical Trials: A Path Forward (Roxana Mehran, MD, FACC, FAHA, MSCAI, FESC)

Rethinking Clinical Trials

         Speaker Roxana Mehran, MD, FACC, FAHA, MSCAI, FESC Mount Sinai Endowed Professor of Cardiovascular Clinical Research and Outcomes Professor of Medicine (Cardiology), and Population Health Science and Policy Director, Interventional Cardiovascular Research and Clinical Trials Director, Women’s Heart and Vascular Center at Mount Sinai Heart Icahn School of Medicine at Mount Sinai Slides Keywords Cardiovascular Health, Interventional Cardiovascular Research, Diversity, Health Di

article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Patient-centric advertising: Zero-party data's healing touch

pharmaphorum

Patient-centric advertising using zero-party data can provide effective and personalised healthcare marketing while ensuring compliance with legal regulations and industry standards.

article thumbnail

Trends in Oncology Study Design, from Optimus to Endpoints

Worldwide Clinical Trials

In November 2023, at Outsourcing Clinical Trials Dach in Zurich, our Executive Director, Oncology Strategy Lead, Matt Cooper , presented “Delivering Oncology Studies – Challenges and Considerations.” His presentation covered various aspects of oncology clinical programs, focusing on study design trends, with reference to both the recently implemented FDA Project Optimus guidance and studies we have seen from sponsors.

Trials 208

More Trending

article thumbnail

Pharma breakthroughs: 10 novel drug approvals that made headlines in 2023 

Pharmaceutical Technology

Pharmaceutical Technology outlines some of the biggest US Food and Drug Administration (FDA) drug approvals announced in 2023 that are set to make an impact in the coming years.

Drugs 263
article thumbnail

As ALS research booms, one treatment center finds itself in the spotlight

Bio Pharma Dive

The Healey center is at the front of ALS research and care, earning acclaim from patients, doctors and scientists. Still, the complexities of the disease and of drug development have brought hard-felt losses.

Research 356
article thumbnail

Landmark Melanoma Vaccine Could Be Available in Just 2 Years

AuroBlog - Aurous Healthcare Clinical Trials blog

Moderna CEO Stephane Bancel told AFP his company’s experimental vaccine against melanoma could be available in as little as two years, in what would amount to a landmark step against the most serious form of skin cancer. Globally there were an estimated 325,000 new melanoma cases and 57 ,000 deaths from the disease in 2020.

article thumbnail

Key Parkinson’s protein could offer new potential targets for treatment

Pharma Times

The findings could lead to new treatments to target the mTOR and ease PD symptoms - News - PharmaTimes

Protein 149
article thumbnail

Optimizing Clinical Supply Strategy: Navigating Challenges & Finding Your Ideal Model

article thumbnail

2023 in review: Cancer vaccines dose up on advances with tailored approaches 

Pharmaceutical Technology

As the number of patients with cancers continues to grow globally, research into personalised cancer vaccines is vital.

article thumbnail

Investors still aren’t sold on UniQure’s gene therapy for Huntington’s

Bio Pharma Dive

The biotechnology company’s share price fell more than 10% Tuesday after the disclosure of more data from a small study.

article thumbnail

New Breakthrough Points to a Future Treatment For Morning Sickness

AuroBlog - Aurous Healthcare Clinical Trials blog

Sickness in pregnancy, or hyperemesis gravidarum, is common and is thought to affect seven out of ten women at some time in their pregnancy. But, until recently, very little has been known about why it happens.

Hormones 246
article thumbnail

Wearable technology to be offered to thousands with type 1 diabetes in UK

Pharma Times

The condition affects around 270,935 people in England and 16,090 people in Wales - News - PharmaTimes

144
144
article thumbnail

The New Age of Decentralized Clinical Trials

White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations

article thumbnail

Vertex secures CHMP nod for Casgevy approval in Europe

Pharmaceutical Technology

Following US and UK approvals, the EMA’s CHMP has recommended conditional approval for Casgevy, with a decision expected in Q1 2024.

264
264
article thumbnail

Merck gets FDA decision date for new pneumococcal vaccine

Bio Pharma Dive

The company’s shot targets 21 strains of pneumococcal bacteria and, if approved, would compete with Pfizer’s Prevnar 20.

Bacteria 284
article thumbnail

The Cause of Alzheimer’s May Be Coming From Inside Your Mouth

AuroBlog - Aurous Healthcare Clinical Trials blog

In recent years, a growing number of scientific studies have backed an alarming hypothesis: Alzheimer’s disease isn’t just a disease, it’s an infection. While the exact mechanisms of this infection are something researchers are still trying to isolate, numerous studies suggest the deadly spread of Alzheimer’s goes way beyond what we used to think.

Research 241
article thumbnail

NHS expands home-testing kits to detect bowel cancer earlier

Pharma Times

Bowel cancer is currently the third most common type of cancer in England - News - PharmaTimes

142
142
article thumbnail

How Machine Learning Drives Clinical Trial Efficiency

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

article thumbnail

Kronos Bio swivels focus towards multiple myeloma after AML failure

Pharmaceutical Technology

Kronos Bio is prioritising its multiple myeloma therapy after reviewing negative Phase Ib AML data for lanraplenib.

246
246
article thumbnail

Bristol Myers to acquire brain drug developer Karuna for $14B

Bio Pharma Dive

The deal would hand Bristol Myers, which has newly made neuroscience a therapeutic focus, an experimental treatment for schizophrenia.

article thumbnail

A Neuroscientist Explains How to Survive The Stress of The Holidays

AuroBlog - Aurous Healthcare Clinical Trials blog

Just as the shift to shorter days and colder weather can bring with it mood swings and other emotional challenges, the holiday season can also bring about somewhat predictable changes in mood and behavior. Around this time of year, many of us experience more stress, anxiety and frustration than usual.

article thumbnail

Cognitive decline in early Alzheimer’s could stem from serotonin loss

Pharma Times

MCI patients had 25% lower levels of serotonin compared to healthy patients - News - PharmaTimes

142
142
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

Sanofi licenses fourth NK cell engager from Innate Pharma

Pharmaceutical Technology

Sanofi and Innate’s cancer collaboration agreement stretches back to 2016, with two of Sanofi’s NK cell engagers in clinical studies.

Licensing 245
article thumbnail

Pivotal Life Sciences reloads with $389M, hunting for deals in a downturn

Bio Pharma Dive

The firm is tracking startups that launched during the biotechnology sector’s peak a few years ago but now need fresh funds to move their programs forward, one of its investors said.

article thumbnail

Veteran pharmacy professor G P Mohanta gets Acharya PC Ray Gold Medal Award

AuroBlog - Aurous Healthcare Clinical Trials blog

The HoD of the Department of Pharmacy Practice at the CL Baid Mehta College of Pharmacy in Chennai, Prof. Guruprasad Mohanta has been bestowed with the prestigious Acharya P C Ray Gold Medal Award 2023 instituted by the Bengal branch of the Indian Pharmaceutical Association (IPA).

Pharmacy 232
article thumbnail

2024 forecast: M&A saw an uptick in 2023. Analysts expect the trend to continue

Fierce Pharma

Even with the Federal Trade Commission keeping a watchful eye on the biopharma industry and the economic landscape giving some players pause, mergers and acquisitions are back on the rise. | Even with the Federal Trade Commission keeping a watchful eye on the biopharma industry and the economic landscape giving some players pause, mergers and acquisitions are back on the rise.

140
140
article thumbnail

European Clinical Supply Planning: Balancing Cost, Flexibility and Time

article thumbnail

Roche and Novartis’ Xolair set for FDA priority review in food allergies

Pharmaceutical Technology

The FDA accepted the filing based on NIH-funded Phase III trial interim results, with an approval decision expected in Q1 2024

Allergies 244
article thumbnail

J&J bets bigger on MeiraGTx’s eye gene therapy

Bio Pharma Dive

Ahead of a Phase 3 readout that could come next year, the pharma is paying $130 million in upfront and near-term cash for rights to the retinitis pigmentosa treatment that it didn’t already own.

article thumbnail

A Dentist Reveals What Happens to Your Teeth as You Get Older

AuroBlog - Aurous Healthcare Clinical Trials blog

A healthy smile helps us live long, well and happy lives. But just like our bodies, our teeth succumb to age-related changes. So what happens to teeth as you age? And what can you do to ensure your smile lasts the distance? [link] First, what are teeth made of?

article thumbnail

Digital health collaboration to trial AI-powered X-rays for lung cancer detection

Pharma Times

Earlier diagnosis could increase patient survival rates by five years or more - News - PharmaTimes

Trials 139
article thumbnail

The New Age of Decentralized Clinical Trials

This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.